Loading publications…
The last 5 uploaded publications
Development and Validation of Nomograms to Predict Outcome Following LuPSMA Radionuclide Treatment for Metastatic Castration-Resistant Prostate Cancer: A Multicenter International Study
Andrei Gafita, Jérémie Calais, Tristan Grogan, Anna Zeldin, Boris Hadaschik, Hui Wang, Manuel Weber, Shahneen Sandhu, Clemens Kratochwil, Rouzbeh Esfandiari, Robert Tauber, Hendrik Rathke, Wesley R. Armstrong, Andrew Robertson, Pan Thin, Calogero D’Alessandria, Matthew B. Rettig, Ebrahim S. Delpassand, Uwe Haberkorn, David Elashoff, Ken Herrmann, Johannes Czernin, Prof Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber (2021). Development and Validation of Nomograms to Predict Outcome Following LuPSMA Radionuclide Treatment for Metastatic Castration-Resistant Prostate Cancer: A Multicenter International Study. , DOI: https://doi.org/10.2139/ssrn.3798566.
Article62 days agoEfficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study
Andrei Gafita, Wolfgang P. Fendler, Hui Wang, Shahneen Sandhu, Manuel Weber, Rouzbeh Esfandiari, Jérémie Calais, Isabel Rauscher, Hendrik Rathke, Robert Tauber, Ebrahim S. Delpassand, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Matthias Eiber, Michael S. Hofman (2020). Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study. , 78(2), DOI: https://doi.org/10.1016/j.eururo.2020.05.004.
Article62 days agoEfficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study
Andrei Gafita, Wolfgang P. Fendler, Hui Wang, Shahneen Sandhu, Manuel Weber, Rouzbeh Esfandiari, Jérémie Calais, Isabel Rauscher, Hendrik Rathke, Robert Tauber, Ebrahim S. Delpassand, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Matthias Eiber, Michael S. Hofman (2020). Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study. , 78(2), DOI: https://doi.org/10.1016/j.eururo.2020.05.004.
Article62 days agoPrognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
Andrei Gafita, Jérémie Calais, Hui Wang, Manuel Weber, Hendrik Rathke, Clemens Kratochwil, Rouzbeh Esfandiari, Wesley R. Armstrong, Shahneen Sandhu, Robert Tauber, Ebrahim S. Delpassand, Uwe Haberkorn, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber (2020). Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.. , 38(15_suppl), DOI: https://doi.org/10.1200/jco.2020.38.15_suppl.5548.
Article62 days ago